Table 1 Clinical and pathological features of breast cancer patients in the study
Variable | Number | % |
|---|---|---|
Stage (TMN) (n = 341) | Â | Â |
I | 124 | 36.4 |
II | 182 | 53.4 |
III | 30 | 8.8 |
IV | 5 | 1.5 |
Grade (n = 343) | Â | Â |
1 | 57 | 16.6 |
2 | 141 | 41.1 |
3 | 145 | 42.3 |
Histological type = 347) | Â | Â |
Ductal | 219 | 63.1 |
Lobular | 56 | 16.1 |
Mix | 35 | 10.1 |
Other | 37 | 10.7 |
Tumor size (n = 346) | Â | Â |
T1 | 201 | 58.1 |
T2 | 120 | 34.7 |
T3 and T4 | 25 | 7.2 |
Nodal status (n = 342) | Â | Â |
Negative | 182 | 53.2 |
Positive | 160 | 46.8 |
ER status (n = 342) | Â | Â |
Negative | 120 | 35.1 |
Positive | 222 | 64.9 |
PR status (n = 341) | Â | Â |
Negative | 163 | 47.8 |
Positive | 178 | 52.2 |
Treatment (n = 348) | Â | Â |
No adjuvant therapy | 45 | 12.9 |
Chemotherapy | 119 | 34.2 |
Endotherapy | 77 | 22.1 |
Chemotherapy and endotherapy | 107 | 30.8 |